Ikarian Capital, LLC
An institutional investment manager in DALLAS, TX. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1778253.
- Reported value$928.2m
- Positions156
Holdings: 156 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| SPDR Series Trust | ST STR SP BIOT | 78464A870 | 47.5 | 5.1% | 300,000 | Put | Reduced−500,000 |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 45.5 | 4.9% | 341,100 | Call | Added+47,800 |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 43.4 | 4.7% | 328,635 | Added+271,000 | |
| Kodiak Sciences IncKOD | COM | 50015M109 | 41.3 | 4.4% | 1,059,730 | Reduced−206,065 | |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 33.3 | 3.6% | 250,000 | Put | New+250,000 |
| Ionis Pharmaceuticals IncIONS | COM | 462222100 | 31.7 | 3.4% | 400,000 | Call | Added+287,900 |
| Moderna IncMRNA | COM | 60770K107 | 28.0 | 3.0% | 400,000 | Put | New+400,000 |
| Alumis IncALMS | COM | 022307102 | 24.5 | 2.6% | 870,548 | Reduced−343,000 | |
| Praxis Precision Medicines IPRAX | COM NEW | 74006W207 | 24.4 | 2.6% | 72,842 | Added+1,261 | |
| Ionis Pharmaceuticals IncIONS | COM | 462222100 | 23.8 | 2.6% | 300,000 | Put | New+300,000 |
| Vaxcyte IncPCVX | COM | 92243G108 | 22.6 | 2.4% | 388,682 | Reduced−40,000 | |
| ANI Pharmaceuticals IncANIP | COM | 00182C103 | 22.5 | 2.4% | 272,085 | Added+125,000 | |
| Celldex Therapeutics Inc NewCLDX | COM NEW | 15117B202 | 17.8 | 1.9% | 478,500 | Added+17,253 | |
| Arcus Biosciences IncRCUS | COM | 03969F109 | 15.6 | 1.7% | 504,559 | New+504,559 | |
| Relmada Therapeutics IncRLMD | COM | 75955J402 | 14.9 | 1.6% | 2,148,359 | Reduced−540,000 | |
| Capricor Therapeutics IncCAPR | COM NEW | 14070B309 | 14.5 | 1.6% | 604,215 | Added+76,200 | |
| Cogent Biosciences IncCOGT | COM | 19240Q201 | 14.3 | 1.5% | 370,084 | New+370,084 | |
| Newamsterdam Pharma Company | PUT | N62509959 | 13.6 | 1.5% | 400,000 | Put | New+400,000 |
| Vera Therapeutics IncVERA | CL A | 92337R101 | 13.3 | 1.4% | 310,000 | Added+110,000 | |
| Contineum Therapeutics IncCTNM | CL A | 21217B100 | 13.2 | 1.4% | 807,874 | Unchanged | |
| Tenax Therapeutics IncTENX | COM NEW | 88032L605 | 11.5 | 1.2% | 787,600 | Reduced−230,000 | |
| C4 Therapeutics IncCCCC | COM STK | 12529R107 | 11.4 | 1.2% | 2,433,000 | New+2,433,000 | |
| Maze Therapeutics IncMAZE | COM | 578784100 | 11.3 | 1.2% | 378,999 | Unchanged | |
| Biohaven Ltd | COM | G1110E107 | 11.1 | 1.2% | 748,181 | Added+335,700 | |
| Connect Biopharma Holdings Ltd | SHS | G23549101 | 10.8 | 1.2% | 4,538,534 | Reduced−849,952 | |
| Alto Neuroscience IncANRO | COM SHS | 02157Q109 | 10.7 | 1.2% | 407,338 | Reduced−107,662 | |
| Pharvaris N V | COM | N69605108 | 10.7 | 1.2% | 308,856 | Reduced−178,000 | |
| Alumis IncALMS | COM | 022307102 | 10.0 | 1.1% | 356,300 | Call | Added+91,700 |
| Jade Biosciences IncJBIO | COM NEW | 008064206 | 9.5 | 1.0% | 427,349 | Reduced−85,000 | |
| Damora Therapeutics Inc | COM NEW | 36322Q206 | 8.7 | 0.9% | 335,710 | Unchanged | |
| Kodiak Sciences IncKOD | COM | 50015M109 | 8.5 | 0.9% | 217,700 | Call | Added+117,700 |
| Capricor Therapeutics IncCAPR | COM NEW | 14070B309 | 8.4 | 0.9% | 350,000 | Call | Unchanged |
| Arrowhead Pharmaceuticals inARWR | COM | 04280A100 | 8.2 | 0.9% | 100,000 | Put | Added+42,500 |
| Viridian Therapeutics IncVRDN | COM | 92790C104 | 7.8 | 0.8% | 425,000 | New+425,000 | |
| Pelthos Therapeutics IncPTHS | COM SHS | 171126204 | 7.3 | 0.8% | 256,598 | Unchanged | |
| Zura Bio Ltd | CLASS A ORD SHS | G9TY5A101 | 7.2 | 0.8% | 1,218,492 | Added+25,000 | |
| Tectonic Therapeutic IncTECX | COM | 878972108 | 7.1 | 0.8% | 205,837 | Added+48,300 | |
| Praxis Precision Medicines IPRAX | COM NEW | 74006W207 | 6.7 | 0.7% | 20,000 | Call | New+20,000 |
| Spruce Biosciences IncSPRB | COM NEW | 85209E208 | 6.6 | 0.7% | 121,356 | Unchanged | |
| Hims & Hers Health IncHIMS | COM CL A | 433000106 | 6.5 | 0.7% | 188,381 | New+188,381 | |
| Enliven Therapeutics IncELVN | COM | 29337E102 | 6.4 | 0.7% | 126,541 | New+126,541 | |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | 6.4 | 0.7% | 3,425,930 | Added+1,933,701 | |
| Bright Minds Biosciences IncDRUG | COM NEW | 10919W405 | 6.2 | 0.7% | 88,951 | Reduced−77,696 | |
| Ovid Therapeutics IncOVID | COM | 690469101 | 6.1 | 0.7% | 2,269,704 | Reduced−625,000 | |
| Ocugen IncOCGN | COM | 67577C105 | 6.1 | 0.7% | 3,962,972 | Unchanged | |
| Alpha Cognition IncACOG | COM NEW | 02074J501 | 6.0 | 0.7% | 836,259 | Reduced−220,000 | |
| Kymera Therapeutics IncKYMR | COM | 501575104 | 5.8 | 0.6% | 50,400 | Put | Unchanged |
| Harrow IncHROW | COM | 415858109 | 5.8 | 0.6% | 135,775 | Reduced−407,272 | |
| Kazia Therapeutics LtdKZIA | SPONSORED ADS | 48669G303 | 5.6 | 0.6% | 396,201 | New+396,201 | |
| Ultragenyx Pharmaceutical inRARE | COM | 90400D108 | 5.5 | 0.6% | 165,617 | Reduced−316,954 | |
| Q32 Bio IncQTTB | COM | 746964105 | 5.5 | 0.6% | 430,000 | New+430,000 | |
| Tenax Therapeutics IncTENX | COM NEW | 88032L605 | 5.4 | 0.6% | 373,100 | Call | Added+258,800 |
| Eupraxia Pharmaceuticals IncEPRX | COM | 29842P105 | 5.4 | 0.6% | 809,741 | Reduced−405,000 | |
| Eyepoint IncEYPT | COM NEW | 30233G209 | 5.3 | 0.6% | 370,400 | Put | Unchanged |
| Eyepoint IncEYPT | COM NEW | 30233G209 | 5.3 | 0.6% | 370,400 | Call | Unchanged |
| Sellas Life Sciences Group ISLS | COM NEW | 81642T209 | 5.2 | 0.6% | 354,700 | Put | New+354,700 |
| Bioage Labs IncBIOA | COM | 09077V100 | 4.9 | 0.5% | 200,000 | New+200,000 | |
| Rezolute IncRZLT | COM NEW | 76200L309 | 4.9 | 0.5% | 935,012 | Added+918,533 | |
| Olema Pharmaceuticals IncOLMA | COM | 68062P106 | 4.8 | 0.5% | 383,281 | Reduced−215,000 | |
| Sionna Therapeutics IncSION | COM | 829401108 | 4.7 | 0.5% | 107,500 | Put | New+107,500 |
| Monopar Therapeutics IncMNPR | COM NEW | 61023L207 | 4.4 | 0.5% | 47,861 | New+47,861 | |
| Bridgebio Pharma IncBBIO | COM | 10806X102 | 4.3 | 0.5% | 57,417 | Reduced−102,703 | |
| Celldex Therapeutics Inc NewCLDX | COM NEW | 15117B202 | 4.2 | 0.5% | 114,000 | Put | Unchanged |
| Inventiva SAIVA | ADS | 46124U107 | 4.2 | 0.4% | 1,129,101 | Reduced−300,000 | |
| Absci CorporationABSI | COM | 00091E109 | 4.1 | 0.4% | 353,772 | New+353,772 | |
| Alector IncALEC | COM | 014442107 | 4.0 | 0.4% | 1,982,606 | Reduced−100,000 | |
| Climb Bio IncCLYM | COM | 28658R106 | 3.9 | 0.4% | 300,000 | New+300,000 | |
| Fulcrum Therapeutics IncFULC | COM | 359616109 | 3.8 | 0.4% | 1,049,161 | Unchanged | |
| Cardiol Therapeutics IncCRDL | COM CL A | 14161Y200 | 3.5 | 0.4% | 3,325,000 | Added+600,000 | |
| CUE Biopharma IncCUE | COM | 22978P205 | 3.3 | 0.4% | 104,364 | New+104,364 | |
| Cumberland Pharmaceuticals ICPIX | COM | 230770109 | 3.3 | 0.4% | 503,153 | Reduced−50,000 | |
| Arrowhead Pharmaceuticals inARWR | COM | 04280A100 | 3.1 | 0.3% | 38,278 | New+38,278 | |
| Vera Therapeutics IncVERA | CL A | 92337R101 | 3.1 | 0.3% | 71,700 | Call | Unchanged |
| Rein Therapeutics IncRNTX | COM NEW | 00887A204 | 3.1 | 0.3% | 2,950,000 | New+2,950,000 | |
| Arvinas IncARVN | COM | 04335A105 | 3.0 | 0.3% | 358,257 | Unchanged | |
| Acumen Pharmaceuticals IncABOS | COM | 00509G209 | 2.8 | 0.3% | 1,053,797 | Unchanged | |
| Promis Neurosciences IncPMN | COM SHS | 74346M505 | 2.7 | 0.3% | 205,000 | Added+150,000 | |
| Q32 Bio IncQTTB | COM | 746964105 | 2.5 | 0.3% | 200,000 | Put | New+200,000 |
| Olema Pharmaceuticals IncOLMA | COM | 68062P106 | 2.5 | 0.3% | 200,000 | Call | Reduced−349,800 |
| Annexon IncANNX | COM | 03589W102 | 2.5 | 0.3% | 430,244 | Reduced−150,000 | |
| Bristol-Myers Squibb CoBMY | COM | 110122108 | 2.4 | 0.3% | 42,500 | Put | Reduced−457,500 |
| Lexeo Therapeutics IncLXEO | COM | 52886X107 | 2.4 | 0.3% | 513,011 | Unchanged | |
| Delcath Sys IncDCTH | COM NEW | 24661P807 | 2.3 | 0.3% | 185,667 | Reduced−245,584 | |
| Invivyd IncIVVD | COM | 00534A102 | 2.3 | 0.2% | 2,656,570 | Unchanged | |
| Uniqure NV | CALL | N90064901 | 2.3 | 0.2% | 49,800 | Call | Reduced−305,200 |
| Cabaletta Bio IncCABA | COM | 12674W109 | 2.2 | 0.2% | 700,000 | Reduced−200,000 | |
| Neumora Therapeutics Inc.NMRA | COM | 640979100 | 2.2 | 0.2% | 1,278,408 | Unchanged | |
| Amylyx Pharmaceuticals IncAMLX | COM | 03237H101 | 2.1 | 0.2% | 117,500 | New+117,500 | |
| Tarsus Pharmaceuticals IncTARS | COM | 87650L103 | 2.0 | 0.2% | 31,166 | Unchanged | |
| Silence Therapeutics plcSLN | ADS | 82686Q101 | 1.8 | 0.2% | 830,784 | Reduced−35,000 | |
| Journey Med CorpDERM | COM | 48115J109 | 1.8 | 0.2% | 251,436 | Unchanged | |
| DBV Technologies S aDBVT | SPONSORED ADS | 23306J309 | 1.7 | 0.2% | 525,000 | Unchanged | |
| Ibio IncIBIO | COM NEW | 451033708 | 1.7 | 0.2% | 957,062 | Unchanged | |
| Avalo Therapeutics IncAVTX | COM NEW | 05338F306 | 1.7 | 0.2% | 90,183 | New+90,183 | |
| Anteris Technologies GlobalAVR | COM | 03675P102 | 1.6 | 0.2% | 166,571 | Reduced−200,000 | |
| Palisade Bio IncPALI | COM | 696389402 | 1.6 | 0.2% | 750,000 | Added+475,022 | |
| Amanat Acquisition Corp | CL A ORD | G0375M101 | 1.5 | 0.2% | 150,000 | New+150,000 | |
| Kalaris Therapeutics IncKLRS | COM | 482929106 | 1.5 | 0.2% | 360,000 | Unchanged | |
| Quince Therapeutics IncIRLA | COM | 22053A305 | 1.3 | 0.1% | 72,251 | New+72,251 | |
| Lipocine Inc NewLPCN | COM NEW | 53630X203 | 1.3 | 0.1% | 508,556 | Unchanged | |
| Immunome IncIMNM | COM | 45257U108 | 1.3 | 0.1% | 60,000 | New+60,000 | |
| Pliant Therapeutics IncPLRX | COM | 729139105 | 1.1 | 0.1% | 1,000,000 | New+1,000,000 | |
| Immunic IncIMUX | COM NEW | 4525EP200 | 1.0 | 0.1% | 67,464 | New+67,464 | |
| Quoin Pharmaceuticals LtdQNRX | SPONSORED ADS | 74907L409 | 1.0 | 0.1% | 211,538 | Unchanged | |
| Disc Medicine IncIRON | COM | 254604101 | 1.0 | 0.1% | 13,300 | Call | New+13,300 |
| Disc Medicine IncIRON | COM | 254604101 | 1.0 | 0.1% | 13,300 | Put | New+13,300 |
| Equillium IncEQ | COM | 29446K106 | 1.0 | 0.1% | 303,555 | Unchanged | |
| Neuronetics IncSTIM | COM | 64131A105 | 0.9 | <0.1% | 701,182 | Unchanged | |
| Faeth Therapeutics IncFTH | COM NEW | 81728A207 | 0.9 | <0.1% | 35,386 | Added+29,035 | |
| Fractyl Health Inc | COM | 35168W103 | 0.9 | <0.1% | 1,100,000 | Unchanged | |
| Cybin Inc | COM NEW | 23256X407 | 0.9 | <0.1% | 132,153 | Unchanged | |
| First Tracks BiotherapeuticsTRAX | ORD SHS | 337185102 | 0.9 | <0.1% | 42,775 | New+42,775 | |
| Verastem IncVSTM | COM NEW | 92337C203 | 0.8 | <0.1% | 213,865 | Unchanged | |
| Direxion Shares ETF Trust | DAI BIO BEA ETF | 25461H853 | 0.8 | <0.1% | 105,822 | Unchanged | |
| Pepgen IncPEPG | COM | 713317105 | 0.8 | <0.1% | 447,165 | Unchanged | |
| Acadia Pharmaceuticals IncACAD | COM | 004225108 | 0.7 | <0.1% | 28,099 | Unchanged | |
| CNS Pharmaceuticals IncCNSP | COM | 18978H508 | 0.6 | <0.1% | 135,830 | Added+90,000 | |
| Lyell Immunopharma IncLYEL | COM NEW | 55083R203 | 0.6 | <0.1% | 41,081 | Unchanged | |
| Wave Life Sciences Ltd | SHS | Y95308105 | 0.5 | <0.1% | 85,285 | Unchanged | |
| Immatics N.V | SHS | N44445109 | 0.5 | <0.1% | 48,569 | Unchanged | |
| Passage Bio IncPASG | COM NEW | 702712209 | 0.5 | <0.1% | 99,517 | Added+31,393 | |
| Nextcure IncNXTC | COM NEW | 65343E207 | 0.5 | <0.1% | 288,303 | Added+50,000 | |
| Forte Biosciences Inc | COM NEW | 34962G208 | 0.4 | <0.1% | 20,972 | Reduced−98,000 | |
| Solid Biosciences IncSLDB | COM NEW | 83422E204 | 0.4 | <0.1% | 42,956 | Reduced−221,453 | |
| Elicio Therapeutics IncELTX | COM | 28657F103 | 0.4 | <0.1% | 107,100 | Call | New+107,100 |
| Elicio Therapeutics IncELTX | COM | 28657F103 | 0.4 | <0.1% | 107,100 | Put | New+107,100 |
| Traws Pharma IncTRAW | COM NEW | 68232V884 | 0.4 | <0.1% | 478,142 | Reduced−200,000 | |
| Lexicon Pharmaceuticals IncLXRX | COM NEW | 528872302 | 0.4 | <0.1% | 164,674 | Unchanged | |
| Elicio Therapeutics IncELTX | COM | 28657F103 | 0.4 | <0.1% | 100,000 | New+100,000 | |
| Adlai Nortye LtdANL | SPONSORED ADS | 00704R109 | 0.4 | <0.1% | 33,899 | Unchanged | |
| Inmed Pharmaceuticals IncINM | COM NEW | 457637700 | 0.4 | <0.1% | 245,025 | New+245,025 | |
| Viking Therapeutics IncVKTX | COM | 92686J106 | 0.4 | <0.1% | 9,717 | Unchanged | |
| Macrogenics IncMGNX | COM | 556099109 | 0.3 | <0.1% | 74,893 | Unchanged | |
| Praxis Precision Medicines IPRAX | COM NEW | 74006W207 | 0.3 | <0.1% | 900 | Put | New+900 |
| Tenax Therapeutics IncTENX | COM NEW | 88032L605 | 0.2 | <0.1% | 16,500 | Put | New+16,500 |
| Hyperliquid Strategies IncPURR | COM | 44916Y106 | 0.2 | <0.1% | 30,001 | Unchanged | |
| Evaxion ASEVAX | SPONSORED ADS | 29970R303 | 0.2 | <0.1% | 74,698 | Unchanged | |
| Cartesian Therapeutics IncRNAC | COM NEW | 816212302 | 0.2 | <0.1% | 20,807 | Unchanged | |
| Compass Pathways plcCMPS | SPONSORED ADS | 20451W101 | 0.2 | <0.1% | 15,000 | Reduced−660,000 | |
| Neuphoria Therapeutics IncNEUP | COM | 64136E102 | 0.2 | <0.1% | 47,443 | Unchanged | |
| Voyager Therapeutics IncVYGR | COM | 92915B106 | 0.2 | <0.1% | 53,063 | Unchanged | |
| Vyne Therapeutics Inc | COM | 92941V308 | 0.2 | <0.1% | 264,912 | Unchanged | |
| Biocryst Pharmaceuticals IncBCRX | COM | 09058V103 | 0.2 | <0.1% | 16,756 | New+16,756 | |
| Enveric Biosciences IncENVB | COM SHS | 29405E505 | 0.1 | <0.1% | 100,002 | New+100,002 | |
| PMV Pharmaceuticals IncPMVP | COM | 69353Y103 | 0.1 | <0.1% | 89,136 | Unchanged | |
| Vistagen Therapeutics IncVTGN | COM | 92840H400 | 0.1 | <0.1% | 519,077 | Unchanged | |
| Chemomab Therapeutics LtdCMMB | SPONSORED ADS | 16385C203 | 0.1 | <0.1% | 51,793 | Unchanged | |
| Nyxoah S a | SHS | B6S7WD106 | 0.1 | <0.1% | 47,358 | Unchanged | |
| Airsculpt Technologies IncAIRS | COM | 009496100 | 0.1 | <0.1% | 16,398 | Unchanged | |
| Mangoceuticals IncMGRX | COM NEW | 56270V205 | 0.1 | <0.1% | 138,146 | Unchanged | |
| Compass Therapeutics IncCMPX | COM | 20454B104 | 0.0 | <0.1% | 18,000 | Unchanged | |
| Theriva Biologics IncTOVX | COM NEW | 87164U508 | 0.0 | <0.1% | 112,076 | Unchanged | |
| Glucotrack Inc | COM NEW | 45824Q804 | 0.0 | <0.1% | 45,830 | Unchanged | |
| Aethlon Med Inc | COM NEW | 00808Y604 | 0.0 | <0.1% | 14,364 | Unchanged | |
| Jasper Therapeutics IncJSPR | COM NEW | 471871202 | 0.0 | <0.1% | 24,093 | Unchanged | |
| Biomx Inc | COM NEW | 09090D509 | 0.0 | <0.1% | 19,473 | Unchanged |
Sold out: 46 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| ANI Pharmaceuticals IncANIP | COM | 00182C103 | 0.0 | 0.0% | 0 | Call | Sold out−150,000 |
| Autonomix Med Inc | COM NEW | 05330T205 | 0.0 | 0.0% | 0 | Sold out−18,688 | |
| Avalo Therapeutics IncAVTX | COM NEW | 05338F306 | 0.0 | 0.0% | 0 | Put | Sold out−158,500 |
| Avalo Therapeutics IncAVTX | COM NEW | 05338F306 | 0.0 | 0.0% | 0 | Call | Sold out−401,500 |
| Bridgebio Oncology TherapeutBBOT | COM NEW | 107924102 | 0.0 | 0.0% | 0 | Sold out−270,231 | |
| Bridgebio Pharma IncBBIO | COM | 10806X102 | 0.0 | 0.0% | 0 | Call | Sold out−58,500 |
| Centessa Pharmaceuticals plc | SPONSORED ADS | 152309100 | 0.0 | 0.0% | 0 | Sold out−18,113 | |
| Connect Biopharma Holdings Ltd | SHS | G23549101 | 0.0 | 0.0% | 0 | Call | Sold out−144,600 |
| Cytokinetics IncCYTK | COM NEW | 23282W605 | 0.0 | 0.0% | 0 | Sold out−283,572 | |
| Cytokinetics IncCYTK | COM NEW | 23282W605 | 0.0 | 0.0% | 0 | Put | Sold out−550,500 |
| Cytokinetics IncCYTK | COM NEW | 23282W605 | 0.0 | 0.0% | 0 | Call | Sold out−408,400 |
| Definium Therapeutics IncDFTX | COM SHS | 24477V105 | 0.0 | 0.0% | 0 | Sold out−58,803 | |
| ELI Lilly & CoLLY | COM | 532457108 | 0.0 | 0.0% | 0 | Sold out−6,547 | |
| Enliven Therapeutics IncELVN | COM | 29337E102 | 0.0 | 0.0% | 0 | Put | Sold out−83,700 |
| Immunic Inc | COM | 4525EP101 | 0.0 | 0.0% | 0 | Sold out−674,662 | |
| Insmed IncINSM | COM PAR $.01 | 457669307 | 0.0 | 0.0% | 0 | Sold out−4,214 | |
| Invesco QQQ TR | UNIT SER 1 | 46090E103 | 0.0 | 0.0% | 0 | Put | Sold out−100,000 |
| IO Biotech Inc | COM | 449778109 | 0.0 | 0.0% | 0 | Sold out−1,386,565 | |
| Ionis Pharmaceuticals IncIONS | COM | 462222100 | 0.0 | 0.0% | 0 | Sold out−127,038 | |
| Ishares TR | RUSSELL 2000 ETF | 464287655 | 0.0 | 0.0% | 0 | Put | Sold out−200,000 |
| Jazz Pharmaceuticals plc | SHS USD | G50871105 | 0.0 | 0.0% | 0 | Sold out−12,460 | |
| Kalvista Pharmaceuticals Inc | COM | 483497103 | 0.0 | 0.0% | 0 | Sold out−35,119 | |
| Karyopharm Therapeutics IncKPTI | COM NEW | 48576U205 | 0.0 | 0.0% | 0 | Put | Sold out−920,000 |
| Karyopharm Therapeutics IncKPTI | COM NEW | 48576U205 | 0.0 | 0.0% | 0 | Sold out−733,435 | |
| Karyopharm Therapeutics IncKPTI | COM NEW | 48576U205 | 0.0 | 0.0% | 0 | Call | Sold out−920,000 |
| Kezar Life Sciences Inc | COM NEW | 49372L209 | 0.0 | 0.0% | 0 | Sold out−102,211 | |
| Legend Biotech CorpLEGN | SPONSORED ADS | 52490G102 | 0.0 | 0.0% | 0 | Sold out−226,888 | |
| Maze Therapeutics IncMAZE | COM | 578784100 | 0.0 | 0.0% | 0 | Put | Sold out−14,400 |
| Novo-Nordisk a SNVO | ADR | 670100205 | 0.0 | 0.0% | 0 | Call | Sold out−400,000 |
| Nuvalent Inc | COM | 670703107 | 0.0 | 0.0% | 0 | Sold out−23,594 | |
| Oruka Therapeutics IncORKA | COM | 687604108 | 0.0 | 0.0% | 0 | Sold out−242,021 | |
| Palvella Therapeutics Inc NePVLA | COM | 697947109 | 0.0 | 0.0% | 0 | Sold out−64,626 | |
| Pepgen IncPEPG | COM | 713317105 | 0.0 | 0.0% | 0 | Call | Sold out−300,000 |
| Perceptive Cap Solutions Cor | CL A ORD SHS | G70077105 | 0.0 | 0.0% | 0 | Sold out−240,951 | |
| Replimune Group IncREPL | COM | 76029N106 | 0.0 | 0.0% | 0 | Put | Sold out−300,000 |
| Revolution Medicines IncRVMD | COM | 76155X100 | 0.0 | 0.0% | 0 | Sold out−163,142 | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 0.0 | 0.0% | 0 | Put | Sold out−95,000 |
| Sangamo Therapeutics IncSGMOQ | COM | 800677106 | 0.0 | 0.0% | 0 | Sold out−1,218,671 | |
| Shuttle Pharmactcls Holdings in | COM | 825693401 | 0.0 | 0.0% | 0 | Sold out−68,993 | |
| Soleno Therapeutics Inc | COM | 834203309 | 0.0 | 0.0% | 0 | Sold out−344,123 | |
| Surrozen IncSRZN | COM NEW | 86889P208 | 0.0 | 0.0% | 0 | Sold out−173,107 | |
| Terns Pharmaceuticals Inc | COM | 880881107 | 0.0 | 0.0% | 0 | Put | Sold out−1,200,000 |
| Terns Pharmaceuticals Inc | COM | 880881107 | 0.0 | 0.0% | 0 | Sold out−1,456,378 | |
| Uniqure NV | SHS | N90064101 | 0.0 | 0.0% | 0 | Sold out−91,060 | |
| Veru IncVERU | COM NEW | 92536C202 | 0.0 | 0.0% | 0 | Sold out−133,517 | |
| VIR Biotechnology IncVIR | COM | 92764N102 | 0.0 | 0.0% | 0 | Sold out−293,258 |
Source: SEC EDGAR, Form 13F-HR, accession 0001420506-26-001820 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.